Clinical Trial: Probiotics and Biomarkers in Irritable Bowel Syndrome

U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07584278) titled 'Probiotics and Biomarkers in Irritable Bowel Syndrome' on April 22.

Brief Summary: The goal of this double-blind parallel-arm randomized controlled trial is to learn if a probiotic supplement (containing a new strain derived from L. reuteri DSM 17938) alters outcomes related to symptom severity and transit time in adults with irritable bowel syndrome (IBS). The main question it aims to answer is:

Does the probiotic alter IBS symptom severity?

Researchers will compare the probiotic to a placebo (a lookalike substance that contains no probiotic) to see if the probiotic works to alter outcomes.

Participants will:

Be randomized to ei...